Total Funding: 1044500000
Headquarters: Berkeley, California, United States
Funding Status: IPO
Employee Number: 501-1000
Estimated Revenue: $10M to $50M
Last Funding Type: Post-IPO Debt
Last Funding Date: 2021-05-11
Investors Number: 21
Founded Date: 1996-01-01
Industry: Tumor-Specific Antigens